The abstract is read at the publisher; the summary is JClub's.
Serologic immunity to hepatitis A virus in US adults is 39.5% (95% CI, 37.7%-41.3%), leaving about 89.4 million adults susceptible despite national vaccination.
- Why it matters: Protection against acute HAV and HBV infection depends on existing antibodies, yet contemporary, nationally representative immunity estimates—especially within high-risk clinical groups—are limited.
- What they did: In a cross-sectional analysis of National Health and Nutrition Examination Survey data (Jan 2017–Aug 2023) for adults ≥20 years (n=13,514), the study estimated HAV antibody positivity and HBV surface antibody positivity, using survey-weighted logistic regression to identify associated factors.
- The result: HAV immunity was linked to younger age, lower education, and several race/ethnicity groups, and obesity was associated with lower odds; in high-risk subgroups it ranged from 26.7% to 63.7%, implying persistent susceptibility.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.